Dpharm

September 13, 2022
September 14, 2022
ET
The Westin Copley Place, 10 Huntington Avenue Boston, Massachusetts 02116

DPHARM®️ is the first event in the United States to question how we can disrupt the way clinical research gets done to reduce the burden to patients and physicians. DPHARM presented the first example of a decentralized clinical trial from Pfizer in 2011 and reports annually on the progress of flexible/decentralized trials with patient feedback.

The concept of DPHARM was founded by Pfizer and Janssen who continue to play a key role on the steering committee to deliver a highly relevant and engaging program. DPHARM is the conference where a wide range of pharma companies report on innovation to advance clinical trials.

The fast-forward button was pressed this past year to accommodate patients and PIs and DPHARM challenged and reported on what is sticking to benefit a wide range of therapeutic areas post-pandemic.

Session Information:

Title: The case for empathy in product design

Date: Tuesday, September 13th, 2022

Time: 12:25 p.m. – 12:35 p.m. ET

Whether you’re creating a new drug, device or clinical trial IT product, user empathy is a crucial tool for the success of your idea. With increasing focus on AI, DCTs and an associated increase in subject diversity, empathy for the patient experience is more important than ever. Spending a bit of time looking outwardly will improve data quality, reduce cost and eventually help with the adoption of your end product. In this session, we’ll work through an example and list some activities you can easily fold into your processes that help with listening and perspective-taking.

Speakers

Paul-Boyd-headshot.png

Paul Boyd

Vice President, Experience at Clario

Paul Boyd is the Vice President of Experience at Clario. In that role, Boyd leads a team that helps ensure the users of Clario’s products are happily successful in their clinical trial journey. Boyd’s mandate is to innovate in all aspects of the user’s journey through Product, Services, Onboarding, and Support to create a consistently delightful experience in every interaction with Clario. Boyd believes that diversity in thought and empathy lead to more robust and innovative solutions to life’s stickiest problems. Prior to working at Clario, Boyd successfully drove the re-thinking of clinical trial software at Oracle Health Sciences and previously worked at Microsoft, Phase Forward, Groove Networks and Curaspan Health. Paul started his career with a design consultancy in Ottawa, Canada.